MyFinsight
Home
About
Contact
Back
Income Statement
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com
Download
Download image
Net income (loss)
attributable to common...
-$1,785K
(-236.89%↓ Y/Y)
Convertible and redeemable
preferred stock deemed...
-$1K
(97.87%↑ Y/Y)
Net income (loss)
-$1,784K
(-232.05%↓ Y/Y)
Income (loss) before
income tax expense
-$1,777K
(-230.76%↓ Y/Y)
Income tax expense
$7K
(-12.50%↓ Y/Y)
Total other income
(expense), net
-$526K
(-119.14%↓ Y/Y)
Loss from operations
-$1,251K
(9.94%↑ Y/Y)
Change in fair value of
financial instruments
$134K
(-95.97%↓ Y/Y)
Interest income
$2K
(-66.67%↓ Y/Y)
Product sales, net
$4,825K
(15.99%↑ Y/Y)
Other expense, net
$662K
(18.64%↑ Y/Y)
Total operating
expenses
$6,076K
(9.50%↑ Y/Y)
Research and
development, net
$746K
Amortization of intangible
asset
$107K
Amortization of intangible
asset
$100K
Cost of goods sold
$755K
(-1.82%↓ Y/Y)
General and
administrative
$1,843K
(-18.70%↓ Y/Y)
Selling and marketing
$2,625K
(17.03%↑ Y/Y)
Back